✦ LIBER ✦

Tamoxifen, A Possible Novel Therapy For Systemic Mastocytosis

✍ Scribed by Mian, R.; Korenblat, P.E.

Book ID: 119278823
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 42 KB
Volume: 119
Category: Article
ISSN: 1097-6825
DOI: 10.1016/j.jaci.2006.12.171

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pingueculae in systemic mastocytosis: a

Pingueculae in systemic mastocytosis: a possible association

✍ GRAHAM, J. R. 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

Dasatinib therapy for systemic mastocyto

Dasatinib therapy for systemic mastocytosis: four cases

✍ Duncan Purtill; Julian Cooney; Raja Sinniah; Ben Carnley; Gavin Cull; Bradley Au 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Cladribine a good prospect for systemic

Cladribine a good prospect for systemic mastocytosis

📂 Article 📅 2004 🏛 Adis International Limited (now part of Wolters Kl ⚖ 151 KB

Kyphoplasty for vertebral involvement of

Kyphoplasty for vertebral involvement of systemic mastocytosis

✍ C. Hamann; A. Krüger; C. Brendel; A. Ramaswamy; M. Schnabel; A. Neubauer; L.C. H 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 69 KB

B cells in systemic sclerosis: A possibl

B cells in systemic sclerosis: A possible target for therapy

✍ Silvia Bosello; Giacomo De Luca; Barbara Tolusso; Gina Lama; Cristiana Angelucci 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 366 KB

Phase II study of imatinib mesylate as t

Phase II study of imatinib mesylate as therapy for patients with systemic mastocytosis

✍ Arturo Vega-Ruiz; Jorge E. Cortes; Matjaz Sever; Taghi Manshouri; Alfonso Quintá 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 375 KB

Gain-of-function D816V point mutation within the kinase domain of the transmembrane receptor KIT is found in the great majority of patients with systemic mastocytosis (SM) and is attractive therapeutic target. Twenty patients with SM were enrolled during 2003-2005 in phase II clinical trial with ima